The epidemiology of metabolic dysfunction-associated steatotic liver disease among pediatric patients with type 2 diabetes: Systematic review and meta-analysis
• MASLD affects an estimated 36.61% of pediatric patients with T2D, with substantial variation according to the diagnostic modality used. • This high prevalence underscores the need for early liver health screening in pediatric T2D.
Authors
- Letícia Rocha Campos
- Matheus Romano de Souza (ORCID: https://orcid.org/0000-0001-8339-2035)
- Samira Mohamad Khalil (ORCID: https://orcid.org/0009-0000-7205-9405)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade de Ribeirão Preto (BR)
- Universidad de Buenos Aires (AR)
- Clinics Hospital of Ribeirão Preto (BR)
Publication Details
- Journal
- European Journal of Pediatrics
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1007/s00431-025-06734-0
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00